Synergy Between Food and Pharma Driving South America's Economy

UBM Live

2013/9/4 17:32

AsiaNet 54131

AMSTERDAM, Sept. 04, 2013 /PRN=KYODO JBN/ --

- CPhI South America nurturing growth throughout the region

UBM live announced that this year's recent CPhI South America, which took

place from August 6th to 8th, at the Expo Center Norte in Sao Paulo proved to

be the foremost event for collaborating two integral industries and providing

the opportunity to form symbiotic partnerships with industry leaders to shape

the collective markets.

(Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

South America is undergoing a changing macro-economic environment, with a

burgeoning middle-class and heightened job opportunities, which in turn has

lead to an increased demand for healthcare and the pharmaceutical industry in

general. In Brazil alone, according to information published by the Brazilian

Ministry of Health, the pharmaceutical market turns over R$28billion annually

and it is forecast to reach to R$87billion by 2017. This budding economy proves

that there has never been a better time to invest in the South American pharma

market and CPhI provided the ideal platform for companies to meet with domestic

buyers and suppliers, whilst also creating a networking opportunity to foster

international partnerships.

Embarking upon it's sixth successful edition, CPhI South America joined

forces with Food Ingredients South America (FiSA) & Health Ingredients South

America (HiSA), the region's other primary super-conferences, to help stimulate

further economic development within South America. The collaborative events

attracted many international exhibitors representing the whole supply chain

from countries including United States, Germany, Canada, Japan, China and India

who were all keen to break into the South American market, and were pivotal in

driving economical growth and innovation throughout the region. Signifying the

importance of the co-located shows, attendance figures reached around 10,000

strong which is the most successful turn out to date.

Throughout the three show days an attractive series of lectures were

presented, covering the current pharmaceutical industry trends and perspectives

and keeping attendees up to date on subjects ranging from Drug Master Files

(DMFs) to open innovation and legal procedures. Workshops, international

business round tables and seminars were also offered, of which proved

particularly valuable to international exhibitors and featured hot topics such

as "How to understand regulatory issues in Brazil", conducted by ABRIFAR. An

overview of the regulatory affairs in Brazil was provided showcasing the

favourable regulatory environment which no doubt makes it an ideal place for

international companies to build partnerships and establish themselves.

Furthermore, a particular highlight of this year's show was the model

laboratory, which all attendees were able to experience and learn more about

equipment on offer. The lab presented modern equipment for analysis and

production of tablets, preformulation testing and development of solid

pharmaceutical forms.

Erik Heemskerk, Brand Director Emerging Markets at UBM Live commented,

"Latin America is one of the fastest growing regions for the pharmaceutical

industry and is increasingly becoming a go-to destination for international

companies looking to establish themselves in and form domestic partnerships

with, particularly as the regulatory environment in so favorable. CPhI and its

co-located events showed just how significant the synergy between pharma and

food is and highlighted the growth opportunities that these two industries can

provide when collaborating. The partnership is becoming more necessary as we

see nutraceuticals and supplements play a pivotal role within the healthcare

sector. We are delighted with the turnout at CPhI South America and look

forward to returning next year to provide a perfect gateway to this booming

market."

CPhI South America 2014, with co-located events ICSE and BioPh, will return

alongside FiSA and HiSA, on 5-7 August 2014, at the Expo Centre Norte in Sao

Paulo.

The UBM Live annual schedule of Pharmaceutical events also includes CPhI

Worldwide, ICSE, P-MEC Europe and InnoPack (22-24 October, 2013 at Messe

Frankfurt, Germany); CPhI and P-MEC India (3-5 December, 2013 at the Bombay

Exhibition Centre in Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan

(9-11 April, 2014 in Tokyo); CPhI Russia and IPhEB (16-17 April, 2014 in St

Petersburg, Russia); CPhI, P-MEC and Innopack South East Asia (20-22 May, 2014

in Jakarta, Indonesia); CPhI Istanbul (4-6 June, 2014, Turkey) and CPhI, Hi and

Fi, ICSE, P-MEC, BioPh and LabWorld China (26-28 June, 2014 at SNIEC, Shanghai,

China).

http://www.cphi.com/south-america/